Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Journal of Human Growth and Development ; 33(1):113-123, 2023.
Article in English | Scopus | ID: covidwho-2313778

ABSTRACT

Backgroung: Brazil was slow to implement an expanded testing policy for COVID-19, which may have affected the most vulnerable population's access to testing services. Objective: to evaluate the factors associated with performing the molecular test for COVID-19. Methods: cross-sectional study of secondary data from the COVID-19 panel in the state of Espírito Santo. COVID-19 suspicion notification forms were included between September 11, 2020 and March 2, 2021. Hierarchical logistic regression was used to estimate the odds ratio (OR) with 95% confidence interval (CI95%). Results: 419,771 notification forms were analyzed. The prevalence of performing the molecular teste for COVID-19 was 81.1% (CI95% 81.0-81.2). Elderly (OR= 2.70 – CI95% 2.56-2.85), health professional (OR=1.43 – CI95% 1.36-1.50), chronic cardiovascular disease (OR=1.13 – CI95% 1.09-1.17), diabetes mellitus (OR=1.07 – CI95% 1.01-1.14) and hospitalization (OR=5.95 – CI95% 4.53;7.82) were more likely to have undergone the molecular test. Male sex (OR=0.96 – CI95% 0.94-0.98), black skin color (OR=0.75 – CI95% 0.73-0.78), yellow skin color (OR=0.74 – CI95% 0.71-0.77), residing in the northern health region (OR=0.37 – CI95% 0.36-0.39) and the homeless population (OR=0.76 – CI95% 0.67-0.85) had the lowest chance of having undergone the molecular test. Conclusion: Social, economic, contextual factors and the risk of aggravation of the disease were associated with carrying out the molecular test for COVID-19 in the state of Espírito Santo. Actions are needed to guarantee the access of the most vulnerable population to molecular testing. © The authors (2023), this article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4. 0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1. 0/) applies to the data made available in this article, unless otherwise stated.

2.
Revista Brasileira de Saude Ocupacional ; 46(e48), 2021.
Article in Portuguese | CAB Abstracts | ID: covidwho-1865372

ABSTRACT

Objective: To analyze how COVID-19 contingency plans adopted in Brazilian state capitals and in the Federal District approach the health protection of Primary Health Care (PHC) workers.

3.
Non-conventional | WHO COVID | ID: covidwho-1443896

ABSTRACT

OBJECTIVE: To analyze self-reported sociodemographic and clinical characteristics among individuals aged 2 to 22 years and possible associations with SARS-CoV-2 infection in Espirito Santo, Brazil. METHODS: This was a serial cross-sectional population-based study carried out from May to June 2020. The COVID-19 positivity rate was assessed by serological testing, and associated factors were assessed using Pearson's chi-square test (5% significance level). RESULTS: Among 1,693 individuals aged 2 to 22 years, 6.1% tested positive for COVID-19 and, among these, 35.5% did not present any symptoms. Differences were identified between positive and negative cases regarding the number of symptoms (p-value=0.001). Coughing was reported by 40.4% of positive individuals. Only 14.3% sought health care, namely 29.8% among those who tested positive and 13.3% among those who tested negative (p-value=0.001). CONCLUSION: The percentage of asymptomatic patients can impact the COVID-19 transmission chain in schools and fuel outbreaks of the disease in schools.

4.
Non-conventional | WHO COVID | ID: covidwho-1319546

ABSTRACT

OBJECTIVE: To analyze the association between social determinants and morbidities for the outcomes of hospitalization, intensive care unit admission and death by COVID-19 in Espirito Santo State, Brazil. METHODS: Cross-sectional study with secondary data from confirmed cases of COVID-19, reported in the Notifiable Diseases Information System. Poisson regression was used to estimate the prevalence ratios. RESULTS: 104,384 cases reported between February 28th and September 1st, 2020 were studied. The outcomes under study were more frequent among male, elderly, yellow, followed by black, uneducated and with multimorbidity. There was a higher risk of death among people over the age of 60 (PR=56.31 - 95%CI 34.24;92.61), multimorbidities (PR=3.63 - 95%CI 3.16;4.17), kidney disease (PR=3.42 - 95%CI 2.81;4.15) and neoplasms (PR=3.15 - 95%CI 2.41;4.13). CONCLUSION: The effect of social determinants and morbidities on hospitalization and deaths by COVID-19 is evident.

5.
Jul;
Non-conventional | Jul | ID: covidwho-1299363

ABSTRACT

The process of developing Brazil's COVID-19 immunization plan began belatedly and involved a number of experts, including a technical group responsible for defining priority groups for vaccination. This process was permeated by contradictions between the government and researchers. Finally, on 20 January 2021, the government published an updated version of the plan, which remains limited in scope.

6.
Non-conventional in English | WHO COVID | ID: covidwho-1346344

ABSTRACT

INTRODUCTION: We investigated the association of self-reported comorbidities with fatality risk among individuals infected with Coronavirus disease 2019 (COVID-19) in Espírito Santo State, Brazil. METHODS: We included 212,620 individuals, ≥30 years old. The data were obtained from the COVID-19 panel. Kaplan-Meier curves and Cox regression model were used. RESULTS: COVID-19-positive individuals presenting with chronic conditions were at a higher risk of fatality than individuals without these comorbidities. Age had a significant effect on these relationships. CONCLUSIONS: Comorbidities were associated with an increased risk of fatality. Middle-aged people (30-59 years) with comorbidities should also be considered as a vulnerable group.

7.
adolescent |article |Brazil |Caucasian |child |child health |controlled study |coronavirus disease 2019 |COVID-19 testing |demography |disabled person |Espirito Santo |female |groups by age |headache |human |major clinical study |male |morbidity |mortality rate ; 2022(Revista Brasileira de Saude Materno Infantil)
Article in English | WHO COVID | ID: covidwho-1987231

ABSTRACT

Objectives: to characterize school-aged children, adolescents, and young people’s profile and their associations with positive COVID-19 test results. Methods: an observational and descriptive study of secondary data from the COVID-19 Panel in Espírito Santo State in February to August 2020. People suspected of COVID-19, in the 0–19-years old age group, were included in order to assess clinical data and demographic and epidemiological factors associated with the disease. Results: in the study period, 27,351 COVID-19 notification were registered in children, adolescents, and young people. The highest COVID-19 test confirmation was found in Caucasians and were 5-14 years age group. It was also observed that headache was the symptom with the highest test confirmation. Infection in people with disabilities was more frequent in the confirmed cases. The confirmation of cases occurred in approximately 80% of the notified registrations and 0.3% of the confirmed cases, died. Conclusion: children with confirmed diagnosis for COVID-19 have lower mortality rates, even though many were asymptomatic. To control the chain of transmission and reduce morbidity and mortality rates, it was necessaryto conduct more comprehensive research and promote extensive testing in the population.

8.
Coronavirus, Infections|Hospitalization|Mortality|Social, Determinants|of, Health|Cross-Sectional, Studies|Public, Environmental, &, Occupational, Health ; 2021(Epidemiologia E Servicos De Saude)
Article in Portuguese | WHO COVID | ID: covidwho-1581621

ABSTRACT

Objective: To analyze the association between social determinants and morbidities for the outcomes of hospitalization, intensive care unit admission and death by COVID-19 in Espirito Santo State, Brazil. Methods: Cross-sectional study with secondary data from confirmed cases of COVID-19, reported in the Notifiable Diseases Information System. Poisson regression was used to estimate the prevalence ratios. Results: 104,384 cases reported between February 28th and September 1st, 2020 were studied. The outcomes under study were more frequent among male, elderly, yellow, followed by black, uneducated and with multimorbidity. There was a higher risk of death among people over the age of 60 (PR=56.31 - 95%CI 34.24;92.61), multimorbidities (PR=3.63 - 95%CI 3.16;4.17), kidney disease (PR=3.42 - 95%CI 2.81;4.15) and neoplasms (PR=3.15 - 95%CI 2.41;4.13). Conclusion: The effect of social determinants and morbidities on hospitalization and deaths by COVID-19 is evident.

9.
Coronavirus Infections |Prevalence |Prisons ; 2022(Cadernos de Saude Publica)
Article in Portuguese | WHO COVID | ID: covidwho-1745278

ABSTRACT

The study aimed to estimate the proportion of prison inmates in the state of Espírito Santo, Brazil, with SARS-CoV-2 infection and to present factors associated with positive test result. This was a serological survey conducted from August 31 to September 4, 2020, in the state's 34 prison units. An interview and serological tests were performed for detection of IgG and IgM in the group. A total of 844 prison inmates were assessed, 265 of whom tested positive for COVID-19, indicating 31.64% prevalence (95%CI: 28.44-34.83). Statistically significant associations were seen between positive test and location of the prison in the north of the state (p = 0.001), closed imprisonment (p = 0.002), and male gender (p = 0.005). All symptoms were observed less frequently in the group that tested positive, and there was a low prevalence of comorbidities (0 to 7.1%). The results revealed the characteristics of this vulnerable population and can help target health measures. © 2022 Fundacao Oswaldo Cruz. All rights reserved.

10.
Infectious Diseases ; 2021(Revista De Epidemiologia E Controle De Infeccao)
Article in English | WHO COVID | ID: covidwho-1732528
SELECTION OF CITATIONS
SEARCH DETAIL